Novartis | NVS - Cost Of Sales

Novartis reported $3.84B in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Amgen AMGN:US USD 1.75B 159M
AstraZeneca AZN:LN USD 2.51B 393M
Astrazeneca AZN:US USD 2.51B 393M
Biogen BIIB:US USD 570.9M 101.4M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Canopy Growth Corp WEED:CN CAD 103.65M 10.39M
Catalent CTLT:US USD 762M 2M
Corcept Therapeutics CORT:US USD 1.48M 141K
Drreddys Laboratories RDY:US INR 27.61B 1.8B
Eli Lilly And LLY:US USD 1.55B 31M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Glaxosmithkline GSK:US GBP 2.18B 209M
Horizon Pharma HZNP:US USD 240.79M 6.65M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Johnson & Johnson JNJ:US USD 7.76B 29M
Lannett LCI:US USD 66.62M 4.14M
Merk MRK:US USD 3.36B 519M
Novartis NOVN:VX USD 3.84B 180M
Pacira Pharmaceuticals PCRX:US USD 61.92M 11.24M
Perrigo Ordinary Shares PRGO:US USD 772.7M 35.4M
Pfizer PFE:US USD 9.82B 3.73B
Phibro Animal Health PAHC:US USD 167.26M 3.39M
Prestige Brands PBH:US USD 125.12M 3.14M
Roche Holding ROG:VX 8.95B 613M
Supernus Pharmaceuticals SUPN:US USD 22.95M 2.92M
Teva Pharmaceutical Industries TEVA:US USD 1.78B 101M
Valeant Pharmaceuticals VRX:CN USD 652M 68M
Zoetis ZTS:US USD 651M 45M